Table 3.
Summary of combinatorial immunodepletions modeled in the simulation
Components | No. mts bounda | Minus-end areaa | Conclusion | Table 1 concordance |
---|---|---|---|---|
D, H, M, E | 26.4 ± 3.5 | 2.1 ± 0.8 | Tightly focused | Yes |
D, H, E | 3.8 ± 2.1 | No organization | Yes | |
D, M, E | 5.1 ± 2.2 | No organization | Yes | |
H, M, E | 6.9 ± 3.1 | No organization | Yes | |
D, H, M | 22.7 ± 2.0 | 4.4 ± 0.6 | Loosely focused | Yes |
D, E | 5.2 ± 3.0 | No organization | Yes | |
H, E | 2.2 ± 1.3 | No organization | Yes | |
D, H | 20.2 ± 3.6 | 5.0 ± 1.2 | Loosely focused | Yes |
D, M | 21.9 ± 3.7 | 2.2 ± 0.5 | Tightly focused | Yes |
H, M | 21.0 ± 2.9 | 2.6 ± 0.7 | Tightly focused | Yes |
M, E | 2.2 ± 0.6 | No organization | Yes | |
D | 3.2 ± 0.9 | No organization | N/A | |
H | 2.4 ± 1.8 | No organization | Yes | |
M | 4.8 ± 2.8 | No organization | Yes | |
E | 0.7 ± 0.2 | No organization | N/A |
mts, microtubules.
Ten trials of 30 microtubules each.